Pharma Giant Pays $22M to Settle Alleged Kickback Scheme Involving Charitable Foundations

A keyboard with the word " kickback !" written on it.

Pharma giant Biogen Inc. has become the most recent company to resolve allegations that it violated the False Claims Act by illegally using two charities to pay the co-pays of Medicare patients taking its multiple sclerosis drugs, Avonex and Tysabri. The U.S. Department of Justice announced earlier this month that the Cambridge, Mass.-based company agreed…

Read More